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In recent years, drug expenditure in many health care
systems has grown rapidly and varies from 8.4%
(USA) to 25.6% (Portugal) [1]. The total costs of
drugs prescribed by general practitioners is four times
that of drugs prescribed by hospitals. This rise is due
to a number of factors and measures have been intro-
duced within the last decade to limit this expenditure,
including shift from secondary to primary care [2].
Prescribing is one of the most important health care
interventions, however there are frequently gaps
between optimal prescribing and that achieved in
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Abstract
The aim of this overview was to identify interventions that
change doctor prescribing behaviour and to derive
conclusions for practice and further research.  Relevant
studies (indicating prescribing as a behaviour change) were
located from a database of studies maintained by the
Cochrane Collaboration on Effective Professional Practice.
This register is kept up to date by searching the following
databases for reports of relevant research: DHSS-DATA;
EMBASE; MEDLINE; SIGLE; Resource Database in Continuing
Medical Education (1975-1994), along with bibliographies of
related topics, hand searching of key journals and personal
contact with content area experts.  Randomised controlled
trials and non-equivalent group designs with pre- and post-
intervention measures were included.  Outcome measures
were those used by the study authors.  For each study we
determined whether these were positive, negative or
inconclusive.  Positive studies (+) were those that
demonstrated a statistically significant change in the majority
of outcomes measured at level of p ≤0.05 between the
intervention and control groups.  Negative studies (-)
showed a significant change in the opposite direction and
inconclusive studies (≈) showed no significant change
compared to control or no overall positive findings. 
We identified 79eligible studies which described 96 separate
interventions to change prescribing behaviour.  Of these
interventions, 49 (51%, 41%-61%) showed a positive
significant change compared to the control group but
interpretation of specific interventions is limited due to wide
and overlapping confidence intervals.
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practice [3]. Interventions have been targeted at both
patients (e.g. increasing prescription charges) and
doctors (e.g. feedback of information on drugs and
costs). Despite these measures there remain wide
variations in prescribing costs and volume within
both the primary and secondary sectors.
In the United Kingdom, over two-thirds of general
practitioner contacts end with the issuing of a pre-
scription although decisions made by hospital doctors
exert considerable indirect influence on general prac-
titioner prescribing [2].
Reviews of improving prescribing in both hospital
[4] and ambulatory settings [5] are not new.
Systematic reviews have also been published which
examine the broad questions of effectiveness of
methods to improve professional practice [6,7,8].
However, focused reviews of effectiveness of specific
interventions to change doctor prescribing behaviour
are lacking.
Our aim was to identify interventions that affect
prescribing behaviour and to derive conclusions for
practice and further research. This review was intend-
ed to provide an overview of interventions that influ-




Relevant studies (indicating prescribing as a behaviour
change) were located from a database of relevant
studies maintained by the Cochrane Collaboration on
Effective Professional Practice (CCEPP) up to May 1996
[9]. This register is kept up to date by searching the
following databases for reports of relevant research:
DHSS-DATA; EMBASE; MEDLINE; SIGLE; Resource
Database in Continuing Medical Education (1975-
1994), along with bibliographies of related topics [8],
hand searching of key journals and personal contact
with content area experts.
Selection of studies
The following inclusion criteria were adopted:-
• Study design - randomised controlled trials (RCT)
and non-equivalent group designs with pre post
measures. In the latter studies, participants are allo-
cated by some means other than chance to treat-
ment or control groups [10]. Studies were included
if the intervention(s) was compared with a no inter-
vention control or normal practice group.
• Types of participants - physicians only (includes
those undergoing postgraduate training).
• Types of intervention - professional interventions as
described by Bero et al [9].
That is distribution of educational materials; confer-
ences or educational meetings; interventions that
involve locally deriving consensus recommendations;
educational outreach visits that take place in the par-















ers (educational influentials); patient mediated inter-
ventions in which information given to or received
from patients is intended to influence professional
practice; audit and feedback where physicians receive
summary information on their practice over time;
reminder systems where physicians receive specific
reminders at the time of intervention to enhance a
particular strategy or behaviour; marketing, in which
physicians are targeted by interventions similar to
those used to market commercially specific desired
practices. These were either single or in combination
(multifaceted interventions). 
One of the authors (PG) verified that all studies met
the inclusion criteria.
Table 1 Quality criteria for RCTs
Trial Concealment Follow up of Follow up Blind Baseline Reliable Protection Score
of allocation professionals of patients/ Assessment measurement outcome against
episodes measure contamination
RCT - unit of analysis = physician or practice
Hershey 1988 (78) 4 4 ± 4 4 4 4 13
Schectman 1995 (79) ± 4 ± 4 4 4 ± 11
Johnson 1976 (80) 4 ± 4 ± 4 4 ± 11
Hershey 1986 (81) ± 4 ± 4 4 4 ± 11
Meyer 1991 (82) ± ± 4 4 4 4 ± 11
White 1985 (83) ± ± ± 4 4 4 4 11
Gelbach 1984 (84) ± · ± 4 4 4 ± 9
Landgren 1988 (85) ± ± 4 4 4 4 4 12
Putnam 1985 (86) ± 4 4 ± ± 4 ± 10
Stergachis 1987 (87) · ± 4 4 ± ± · 7
McDonald 1984 (88) · ± ± 4 ± 4 ± 8
Karuza 1995 (89) ± 4 4 4 4 4 4 13
Hopkins 1980 (90) · 4 4 4 ± ± · 8
Cowan 1992 (91) · 4 · 4 ± · ± 6
Tierney 1986 (92) ± ± ± 4 ± 4 · 8
Lobach 1994 (93) ± · · · 4 ± ± 5
Gullion 1988 (94) ± 4 · 4 ± 4 4 10
Stergachis 1990 (95) ± 4 4 4 4 4 ± 12
Avorn 1992 (96) ± 4 · ± ± ± 4 8
Avorn 1983 (97) ± 4 4 4 4 4 4 13
Bjornson 1990 (98) ± ± ± 4 ± ± ± 8
Denig 1990 (99) ± 4 ± 4 4 4 4 12
McDonald 1976 (100) 4 ± ± ± ± ± ± 8
Palmer 1985 (101) ± ± ± ± · 4 4 8
Steele 1989 (102) 4 4 4 4 4 4 ± 13
McConnell 1982 (103) ± 4 4 4 · 4 ± 10
Maiman 1988 (104) ± 4 4 4 ± ± ± 10
McAlister 1986 (105) ± 4 ± ± ± ± ± 8
Ornstein 1991 (106) ± 4 · 4 4 ± ± 9
Soumerai 1993 (107) ± 4 ± · · 4 ± 7
Berings 1994 (108) 4 4 ± ± 4 ± 4 11
Jones 1993 (109) 4 4 ± 4 4 4 ± 12
RCT - unit of analysis = patient or episode of care
Weingarten 1989 (110) · 4 4 ± ± ± · 7
Johnson 1978 (111) · ± 4 4 4 ± · 8
Becker 1989 (112) ± ± · ± ± ± · 5
Rogers 1982 (113) ± ± · 4 ± ± · 6
Kroenke 1990 (114) ± ± 4 ± 4 ± ± 9
Coe 1977 (115) ± ± 4 4 4 4 · 10
Garrett 1986 (116) 4 ± ± ± ± · · 6
Britton 1991 (117) · ± ± 4 4 4 ± 9
Belcher 1990 (118) 4 ± · 4 4 4 4 11
White 1989 (119) ± 4 · ± ± ± ± 7
Rosser 1992 (120) 4 ± ± 4 4 4 · 11
Manheim 1990 (121) ± ± ± 4 ± 4 · 8
Bryce 1995 (122) 4 ± 4 4 4 ± · 10
Lipton 1992 (123) · 4 4 4 4 ± ± 10
Anderson 1994 (124) ± ± ± · 4 4 4 9
Owens 1990 (125) ± ± ± 4 4 4 · 9
Billault 1995 (126) ± ± 4 ± 4 ± · 8
Rubenstein 1989 (127) ± 4 4 ± 4 ± 4 11
Cheney 1987 (128) ± ± 4 ± ± 4 ± 9
Lipton 1994 (129) 4 4 4 4 4 4 · 12
Rodman 1984 (130) 4 ± ± 4 4 4 4 12
Rosser 1991 (131) 4 4 · 4 4 ± ± 10
White 1987 (132) ± 4 4 4 4 4 ± 12
Billi 1987 (133) · · · 4 4 ± 4 7
Buffington 1991 (134) ± ± ± 4 · 4 4 9
Wilson 1988 (135) ± 4 4 4 4 4 4 13
Katon 1995 (136) ± ± 4 4 4 ± · 9
Browner 1994 (137) 4 4 4 4 4 4 ± 13
White 1984 (138) 4 ± 4 4 ± 4 · 10
Linn 1980 (139) 4 4 4 ± ± ± 4 11
German 1987 (140) ± ± 4 ± 4 4 ± 10
Frame 1994 (141) ± ± ± 4 4 4 ± 10
4 = done; ± = not clear; and · = not done and each given a score of 4 = 2; ± = 1; and · = 0
Data extraction
Eligible studies were assigned to each author and the
following categories of data extracted: 1) study
design; 2) setting of care; 3) academic status (i.e.
teaching or non-teaching); 4) country; 5) clinical
problem/area; 6) types of interventions ; and 7) out-
come measures used by the study authors. For each
study we determined whether these were positive,
negative or inconclusive. Positive studies (+) were
those that demonstrated a statistically significant
change in the majority of outcomes measured at level
of p ≤0.05 between the intervention and control
groups. Negative studies (-) showed a significant
change in the opposite direction and inconclusive
studies (≈) showed no significant change compared
to control or no overall positive findings. No attempt
was made to contact the authors for missing data. 
We estimated the proportion of statistically signifi-
cant studies and approximate 95% confidence intervals
using the approach originally described by Clopper and
Pearson and cited in Hedges and Olkin [11].
In addition, quality criteria were assessed indepen-
dently by each author [9]. PG also checked results of
these criteria on 40 of the eligible studies.
Results
One-hundred and forty-five studies were located from
the Cochrane Collaboration on Effective Professional
Practice Register of which 66 were excluded. Reasons
for exclusion were: 1) interrupted time series [12-21];
2) does not deal exclusively with physician prescrib-
ing behaviour or with professional interventions [22-
56]; 3) there was no control/normal practice inter-
vention group [57-69]; 4) data were missing to deter-
mine outcomes between intervention and control
[70-76]; and 5) includes a summary paper of a trial
published in another journal [77].
Quality criteria
For RCTs the following quality criteria were assessed:
concealment of allocation; follow up of professionals;
follow up of patients/episodes; blind assessment;
baseline measurement; reliable outcome measure;
and protection against contamination (Table 1).
Quality criteria for non-equivalent group design stud-
ies included: baseline measurement; characteristics of
studies using second site as control; blind assessment;
protection against contamination; follow-up of
patients; reliable outcome measures; and follow-up of
professionals (Table 2).
Each item was scored as done; not clear or not
done [9]. These were then given scores 2, 1 and 0
respectively. Maximum total score for each study was
14 with a mean of 9.65 (sd 2.01) (Tables 1 and 2).
Furthermore, there was no difference in the mean
quality score before and after the 1990 date of publi-
cation (t-test, mean difference -0.44 [-1.35, 0.47]).
Settings
Sixty-five (82%) of the studies were based in the USA;
3 each in Canada and the UK; 2 each in Australia and
Israel; and 1 each in Mexico, Netherlands, Belgium
and France (Table 3).
Over a third (31) of the studies took place in outpa-
tient settings; 25 in community settings; 12 in hospi-
tals; and 10 in two settings. It was not possible to
characterise the setting in one study [98].
Twenty-seven took place in wholly teaching and 14
in mixed centres; 12 in non-teaching settings; and in
26 studies the teaching status was not clear.
Interventions included in the evaluations included
attempts to modify prescribing practices in a variety of
clinical areas [78-82 84 86 97 101-102 107 111
114 116-117 121 123 125 127 129 132-133 144
150-151 154]; chronic conditions such as diabetes
mellitus [93 100] and asthma [119 122 142]; cardio-
vascular [83 94 98 105 113 115 126 130 132];
infections [85 95 103-104 146]; preventive care [88-
89 91-92 106 110 112 118 120 124 128 131
134-135 137-138 141 147 152 155-156]; psychiat-
ric [96 108 136 140 150]; gastrointestinal [109 109
145 148]; musculo-skeletal [87,143]; surgical condi-
tions [90 139] and problems in childhood [156].
Table 2 Quality criteria for non-equivalent group design studies
Trial Baseline Characteristics Blind Protection Reliable  Follow-up Follow-up Score
measurement of studies assessment against outcome of profes- of patients
using second contami- measures sionals
site as control nation
Non equivalent group design - physician or practice as unit of analysis
Gorton 1995 (142) ± · ± 4 4 4 ± 9
Petersen 1995 (143) 4 · 4 4 4 4 ± 11
McDonald 1976 (144) ± ± 4 4 4 4 4 12
Raisch 1990 (145) 4 4 4 4 · 4 4 12
Klein 1981 (146) 4 4 4 ± ± ± ± 10
Schreiner 1988 (147) 4 · ± 4 ± ± ± 8
Gutierrez 1994 (148) 4 4 4 ± ± · ± 9
Ray 1986 ( 149) · · 4 4 ± 4 ± 8
Mason 1993 (150) ± ± ± 4 ± ± ± 8
Non equivalent group design - patient or episode of care as unit of analysis
Koepsell 1983 (151) ± 4 4 4 4 · · 9
Tape 1993 (152) ± 4 4 ± 4 ± 4 11
Margolis 1992 (153) ± ± 4 · 4 4 ± 9
Fortner 1985 (154) 4 4 4 ± ± ± ± 10
Rodney 1983 (155) ± ± 4 4 ± ± ± 9
Zimmerman 1994 (156) 4 ± 4 4 4 ± 4 12















Table 3 Studies of effects of interventions on prescribing behaviour of doctors
Study Setting Academic Clinical Area Intervention Outcome
status
RCT - unit of analysis = physician or practice
Hershey 1988 (78) USA - outpatient teaching All clinical areas Audit and feedback ≈
Schectman 1995 (79) USA - outpatient mixed Antiulcer drugs Audit and feedback ≈
Johnson 1976 (80) USA - outpatient not clear All clinical areas Audit and feedback ≈
Hershey 1986 (81) USA - outpatient mixed All clinical areas Audit and feedback +
Meyer 1991 (82) USA - outpatient teaching All clinical areas Audit and feedback ≈
White 1985 (83) USA - inpatient mixed Acute MI Conferences + +
Educational materials
Gelbach 1984 (84) USA - community teaching All clinical areas Educational materials + +
Audit and feedback
Landgren 1988 (85) Australia - inpatient mixed Infections Educational materials + +
Outreach
Putnam 1985 (86) USA - mixed not clear All clinical areas Educational materials + ≈
Outreach + audit and feedback
Stergachis 1987 (87) USA - mixed not clear non-steriodals outreach ≈
McDonald 1984 (88) USA - outpatient teaching Influenza Audit and feedback +
Karuza 1995 (89) USA - mixed mixed influenza Conferences + Audit +
and feedback
Hopkins 1980 (90) USA - inpatient teaching Surgical emergencies educational materials ≈
Cowan 1992 (91) USA - outpatient teaching Vaccinations Audit and feedback ≈
Tierney 1986 (92) USA - outpatient teaching Preventive care Audit and feedback +
Lobach 1994 (93) USA - community non-teaching Diabetes mellitus Audit and feedback +
Gullion 1988 (94) USA - mixed non-teaching Hypertension Conferences + Audit ≈
and feedback
stergachis 1990 (95) USA - outpatient not clear Upper respiratory Patient mediated ≈
infections
Avorn 1992 (96) USA - community not clear Psychoactive drugs educational materials + ≈
audit and feedback
Avorn 1983 (97) USA - community not clear Variety of clinical areas i) educational materials i) ≈
ii) educational materials + ii) ≈
audit and feedback
Bjornson 1990 (98) USA - not clear not clear Heart failure educational materials ≈
Denig 1990 (99) Netherlands - unclear Irritable Bowel educational materials ≈
community Syndrome
McDonald 1976 (100) USA - outpatient non-teaching Diabetes audit and feedback +
Palmer 1985 (101) USA - community mixed Variety of clinical areas educational materials + confe- ≈
rences + audit and feedback
Steele 1989 (102) USA - outpatient teaching Variety of clinical areas i) Outreach + audit and ≈
feedback
ii) Audit and feedback ≈
McConnell 1982 (103) USA - outpatient non-teaching Upper respiratory tract Outreach +
infections
Maiman 1988 (104) USA - community not clear Otitis media i) Educational materials i) +
ii) Educational materials + ii) ≈
conferences
McAlister 1986 (105) Canada - community not clear Hypertension Educational materials + patient 
mediated + audit and feedback ≈
Ornstein 1991 (106) USA - community teaching Preventive care i) conferences + patient i) ≈
mediated + audit and feedback
ii) conferences + audit and ii) ≈
feedback
iii) conferences + patient iii) ≈
mediated
Soumerai 1993 (107) USA - inpatient mixed Blood transfusion conferences + distribution of +
educational methods + 
outreach + marketing
Berings 1994 (108) Belgium - outpatient non-teaching Anxiety/insomnia i) educational materials i) +
ii) educational materials + ii) +
outreach
Jones 1993 (109) England -  mixed Dyspepsia educational materials +
community
RCT - unit of analysis = patient or episode of care
Weingarten 1989 (110) Israel - community not clear Preventive care Audit and feedback +
Johnson 1978 (111) USA - outpatient non-teaching All clinical areas Audit and feedback ≈
Becker 1989 (112) USA - outpatient teaching Preventive care i) Audit and feedback + i) ≈
patient mediated
ii) Audit and feedback ii) ≈
Rogers 1982 (113) USA - outpatient teaching Hypertension Audit and feedback ≈
Kroenke 1990 (114) USA - outpatient teaching All clinical areas - Elderly Audit and feedback ≈
Coe 1977 (115) USA - outpatient not clear Hypertension Audit and feedback ≈
Garrett 1986 (116) USA - outpatient not clear Variety of clinical areas Audit and feedback +
Britton 1991 (117) USA - outpatient not clear Variety of Clinical areas Audit and feedback ≈
Belcher 1990 (118) USA - outpatient mixed Preventive care Educational materials + confe- ≈
rences + patient reminders + 
audit and feedback
White 1989 (119) England - not clear Asthma Educational materials + patient ≈
community reminders +audit and feedback
Rosser 1992 (120) USA - community teaching Preventive care i) Patient mediated - telephone i) +
ii) Patient mediated - letter ii) +
iii) audit and feedback - iii) +
computer
Table 3 Continued
Manheim 1990 (121) USA - inpatient teaching All clinical areas Educational materials + confe- ≈
rences + audit and feedback
Bryce 1995 (122) Scotland not clear Asthma Educational materials + patient +
- community reminders + audit and feedback
Lipton 1992 (123) USA - mixed non-teaching All clinical areas Patient mediated +
Anderson 1994 (124) USA - inpatient mixed Preventive care i) Educational materials + i) +
outreach
ii) Educational materials + ii) +
outreach + audit and feedback
Owens 1990 (125) USA - inpatient teaching All clinical areas Audit and feedback + +
patient mediated
Billault 1995 (126) France - mixed not clear hypertension Patient mediated ≈
Rubenstein 1989 (127) USA - community non-teaching various clinical areas Educational materials + confe- ≈
rences + audit and feedback
Cheney 1987 (128) USA - outpatient teaching Vaccinations Audit and feedback +
Lipton 1994 (129) USA - inpatient non-teaching various clinical areas Patient mediated + audit and +
feedback
Rodman 1984 (130) USA - inpatient teaching CCU audit and feedback ≈
Rosser 1991 (131) Canada - communityteaching Preventive care i) audit and feedback - com- i) +
puterised decision support
ii) Patient mediated - letters ii) +
iii) Patient mediated - telephone iii) +
White 1987 (132) USA - inpatient teaching Warfarin audit and feedback - compu- ≈
terised decision support
Billi 1987 (133) USA - inpatient teaching various clinical areas Educational materials + +
conferences
Buffington 1991 (134) USA - community not clear Vaccination i) audit and feedback i) +
ii) audit and feedback + ii) +
Patient mediated - letter
Wilson 1988 (135) Canada - community mixed Smoking cessation i) Outreach ≈
ii) Educational materials + +
conferences
Katon 1995 (136) USA - community non-teaching Depression conferences + Audit and +
feedback + patient mediated
Browner 1994 (137) USA - outpatient non-teaching Hypercholesterolaemia i) conferences ≈
ii) conferences + educational ≈
materials
White 1984 (138) USA - inpatient teaching Digoxin intoxication Audit and feedback +
Linn 1980 (139) USA - mixed mixed Burn care Educational materials + confe- +
rences + audit and feedback
German 1987 (140) USA - outpatient teaching Mental health problemsAudit and feedback ≈
Frame 1994 (141) USA - community non-teaching Vaccination Audit and feedback -compu- +
terised decision support
Non equivalent group design - physician or practice as unit of analysis
Gorton 1995 (142) USA - mixed mixed Asthma i) Educational materials + i) ≈
conferences
ii) Educational materials + ii) ≈
conferences (computer)
iii) Educational materials + iii) ≈
conferences (multimedia)
Petersen 1995 (143) Tasmania not clear Allopurinol Educational materials + +
- community outreach
McDonald 1976 (144) USA - outpatient not clear Various clinical areas audit and feedback - +
computerised decision support
Raisch 1990 (145) USA - community not clear Antiulcer drugs Educational materials + outreach ≈
Klein 1981 (146) USA - outpatient teaching Urinary tract infections conferences +
Schreiner 1988 (147) USA - outpatient teaching Vaccination audit and feedback +
Gutierrez 1994 (148) Mexico - community not clear Diarrhoea Conferences + audit and + 
feedback
Ray 1986 (149) USA - mixed not clear Diazepam Educational materials + outreach ≈
Mason 1993 (150) USA - outpatient teaching Variety of clinical areas Outreach +
Non equivalent group design - patient or episode of care as unit of analysis
Koepsell 1983 (151) USA - outpatient teaching All clinical areas Audit and feedback - com- ≈
puterised decision support
Tape 1993 (152) USA - outpatient mixed Vaccination Audit and feedback +
Margolis 1992 (153) Israel - community not clear Childhood problems Audit and feedback - com- +
puterised decision support
Fortner 1985 (154) USA - community not clear All clinical areas conferences + patient mediated + 
+ audit and feedback
Rodney 1983 (155) USA - outpatient teaching Vaccination Audit and feedback + +
conferences
Zimmerman 1994 (156) USA - mixed not clear Histamine antagonists Educational materials + +
audit and feedback

















Within the 79 eligible studies [78-156], there were 96
separate interventions apart from the non-interven-
tion controls.
To aid presentation, the nine interventions detailed
above were grouped into six categories: distribution
of educational materials; audit and feedback (includes
local consensus processes and reminders); outreach (-
includes local opinion leaders); patient mediated;
conferences; and marketing. 
Table 3 shows that 53 studies reported single inter-
ventions and the remaining 26 studies were multifac-
eted. Of the single interventions, audit and feedback
were most common.
Forty-nine (49/96) of the interventions showed a
positive significant change compared to the control
group (Table 4). Note that none of the studies
showed a negative effect as we were interested in
those studies that demonstrated a statistically signifi-
cant change in the majority of outcomes.
Studies that have used patient mediated interven-
tions only yield the highest proportion of positive
results. Next come interventions which provide out-
reach (‘academic detailing’) and audit and feedback
(including reminders). The least effective were distri-
bution of educational materials (43%, 13%-78%).
Of the multifaceted interventions, just under fifty
percent (49%, 20%-80%) were positive.
Overall, 51% (41%-61%) of the intervention dem-
onstrated a significant change.
The number of positive results was lower in studies
that were set in the USA compared to the other coun-
tries (table 5). 
There is no difference in the studies reporting a
positive result with the proportion of studies above
and below the median quality score (table 6). 
Discussion
This overview has shown that a number of studies, in
primary and secondary settings, are available which
address interventions that tend to influence prescrib-
ing. The interventions are varied and have been used
in various combinations. Further, the majority have
been set in the USA and the results may not apply
elsewhere.
It is interesting that inspite of the high proportion
of studies that show positive results that were unlikely
to be accounted for by chance, no clear differences
between approaches can be seen, with the exception
of the distribution of printed educational materials
which has been used widely in combination with
other active interventions, but where used alone has
proven unimpressive.
Vote counting is an inefficient use of the statistical
information in studies, and the poor reporting of
results makes the use of more formal methods for
pooling data and calculating effect size problematic
[11].
Publication bias is the most important potential
source of bias in systematic reviews [157]. Although
considerable efforts have gone into locating relevant
Table 4 Types of interventions aimed at changing doctor prescribing behaviour
No. of Positive % Positive 95% CI
interventions findings interventions
Intervention distribution of educational materials 7 3 43 13, 78
audit and feedback 33 17 52 34, 66
outreach 4 2 50 10, 90
patient mediated 8 5 63 30, 90
conferences 1 1 100 -
marketing 0 0 0 -
multifaceted* 43 21 49 20, 80
Overall 96 49 51 41, 61
* two or more of the above interventions
Table 5 Country of study
Country Positive interventions No of interventions % Positive interventions (95% CI)
USA 36 78 46 (33, 59)
other 13 18 72 (43, 95)
Table 6 Outcome of studies against score
Positive findings Total no of studies % Positive studies (95% CI)
≤9 18 37 49 (32, 65)
Median quality score ‡ 10 22 42 52 (34, 63)
studies, it is likely that some have not been included
in this review. We decided a priori not to include time
series designs. Auto regressive integrated moving
average models which are widely used in time series
analysis [10], are required to take into account the
non independent nature of observations from the
same population over time, and this is very rarely
robustly undertaken in the literature [3]. However, the
relatively small number of time series data sets identi-
fied would be unlikely to reverse the results from
other included designs in this review. Although ran-
domised trials provide the most valid estimates of
effect, time series designs deserve further considera-
tion in the future as they may be used in situations
where experimental designs are not possible, such as
national guideline implementation programmes or
mass media interventions. We found 9 non-random-
ised trials, which are potentially open to bias, and it
was not clear in most cases why a decision had been
made not to allocate by chance (and thus increase
the validity of the trial results). In future trials random-
isation should be considered more frequently [158].
Study limitations
Even though the CCEPP database has been rigorously
developed publication bias has to be considered as the
search strategy may not have identified important neg-
ative results from trials. In addition the database
includes studies that use quantitative methodologies
(RCTs, Controlled trials and Interrupted Time Series)
and valuable results from qualitative studies which pro-
vide insight into behaviour change have been excluded.
Data extraction has been difficult, as the reporting
of details and results has been incomplete or vague.
We did not contact the authors for further clarification
of data.
Some of these studies used multiple outcome meas-
ures ( e.g. number prescriptions/patient and % gener-
ic prescribing) and for these studies, a positive finding
was that which had majority significant findings.
Studies are also subject to another analysis error
where, for example, the unit of allocation is a health
care provider but the analysis is based upon the num-
ber of patients or pills. This could under power the
individual study and thereby increase the chance of a
spuriously significant finding [159]. 
Implications
This review has shown that 51% of interventions
studied may have changed prescribing behaviour and
a number of research issues are raised. For example,
distribution of educational materials alone appear to
have little and multifaceted interventions some effect
on changing behaviour. Interventions which change
doctor prescribing behaviour are complex - there are
no “magic bullets” [7]. Further work, in collaboration
with the Cochrane Collaboration on Effective
Professional Practice [9], is advocated on disentan-
gling the characteristics of these effective interven-
tions that acknowledge the personal, environmental
and behavioural factors [160-161]. Also, primary
studies are needed which take into account these
effective interventions; are multidisciplinary; and
which combine both the quantitative and qualitative
methodologies.
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